Given their potential for myelin repair, OPCs are a promising target for therapeutic interventions in demyelinating diseases. Strategies to enhance the proliferation, migration, and differentiation of OPCs are being explored to promote remyelination. Additionally, stem cell-based therapies that involve the transplantation of OPCs are being investigated as potential treatments for MS and other demyelinating conditions.
